Regioselective Intramolecular Pauson–Khand Reactions of C60
FULL PAPER
Compound 3d: Yield 95%. 1H NMR (CDCl3, 298 K, 500 MHz, mixture
or rotamers): d=2.79 (m, 1H), 2.95 (m, 1H), 3.42, 3.35 (brd, brd, 1H),
3.89, 3.61 (m, brm, 1H), 5.69, 5.49 (d, d, J=11.5 Hz, 1H), 6.19, 4.96 (d,
d, J=12.6 Hz, 1H), 6.37, 5.94 ppm (brt, brm, 1H); 13C NMR (CDCl3,
298 K, 125 MHz, mixture of rotamers): d=14.0, 22.6, 29.6, 31.6, 66.4,
70.3, 72.5, 72.7, 72.9, 73.1, 73.5, 74.4, 96.1, 139.8, 140.3, 141.7, 141.9, 142.1,
142.7, 142.77, 143.1, 143.2, 144.4, 144.48, 144.5, 144.57, 144.6, 144.7,
144.73, 145.3, 145.37, 145.4, 145.44, 145.5, 144.53, 145.6, 145.66, 145.7,
146.1, 146.2, 146.3, 146.35, 146.4, 146.45, 146.6, 147.39, 147.4, 147.44,
149.5, 150.3, 152.3, 164.2 ppm; FTIR (KBr): n˜ =1655, 1410, 526 cmꢀ1; MS
(ESI): m/z: 900 [M+H]+.
9.5 Hz, 1H; CH2N), 5.01 (d, J=9.5 Hz, 1H; CH2N), 5.37 (s, 1H; CHN),
ꢀ
ꢀ
7.23–7.31 (m, 1H; Ar H), 7.42–7.54 (m, 2H; Ar H), 8.09 ppm (m, 1H;
ꢀ
Ar H); 13C NMR (CDCl3/CS2, 298 K, 50 MHz): d=0.05, 39.8, 69.2, 69.7,
79.6, 100.8, 103.4, 124.0, 127.8, 129.0, 120.3, 132.3, 133.1, 134.8, 135.7,
136.5, 139.4, 139.7, 140.06, 140.1, 141.6, 141.63, 141.64, 141.87, 141.9,
142.0, 142.06, 142.07, 142.12, 142.15, 142.2, 142.4, 142.45, 142.5, 142.9,
143.0, 144.2, 144.4, 144.49, 144.5, 145.0, 145.1, 145.13, 145.16, 145.2, 145.3,
145.35, 145.4, 145.5, 145.6, 145.8, 145.85, 145.9, 145.97, 146.0, 146.1,
146.15, 146.2, 146.4, 146.8, 147.2, 153.3, 153.7, 154.5, 156.3 ppm; FTIR
(KBr): n˜ =526, 760, 842, 866, 1230, 1247, 1463, 1506 cmꢀ1; MS (ESI): m/z:
950.3 [M+H]+.
1
Compound 10 f: Yield 90%. H NMR (CDCl3/CS2, 298 K, 300 MHz): d=
Compound 10c: Yield 43% (55%). 1H NMR (CDCl3/CS2, 298 K,
300 MHz): d=0.25 (s, 9H; (CH3)3Si), 2.80 (s, 3H; CH3), 3.88 (s, 3H;
OCH3), 3.96 (s, 3H; OCH3), 4.33 (d, J=9.5 Hz, 1H; CH2N), 4.99 (d, J=
0.03 (s, 9H; (CH3)3Si), 5.83 (d, J=12.7 Hz, 1H; CH2N), 6.36 (brd, 1H;
ꢀ
ꢀ
CH2N), 7.32–7.37 (m, 1H; H Ar), 7.45–7.54 (m, 5H; H Ar), 7.60 (s, 1H;
CHN), 7.62–7.68 (m, 2H; H Ar), 8.12–8.14 ppm (m, 1H; H Ar); 13C
NMR (CDCl3/CS2, 298 K, 75 MHz): d=ꢀ0.2, 62.0, 66.3, 69.5, 71.5, 76.4,
101.8, 103.7, 123.4, 125.5, 127.9, 128.6, 129.2, 130.3, 131.0, 133.8, 134.9,
135.4, 136.0, 136.4, 136.6, 139.64, 139.7, 140.5, 140.8, 142.05, 142.06, 142.1,
142.3, 142.4, 142.44, 142.46, 142.5, 142.7, 143.0, 143.07, 143.1, 143.13,
143.45, 144.7, 144.8, 144.9, 145.0, 145.5, 145.6, 145.7, 145.75, 145.8, 145.9,
146.0, 146.06, 146.2, 146.4, 146.5, 146.6, 146.66, 146.7, 146.76, 146.8,
146.82, 146.84, 147.7, 147.9, 151.9, 154.0, 154.7, 155.8, 171.7 ppm; FTIR
9.5 Hz, 1H; CH2N), 5.63 (s, 1H; CHN), 6.99 (s, 1H; Ar H), 7.60 ppm (s,
ꢀ
ꢀ
ꢀ
1H; Ar H); 13C NMR (CDCl3/CS2, 298 K, 75 MHz): d=0.5, 40.5, 56.3,
ꢀ
56.7, 69.7, 70.2, 80.1, 99.5, 103.9, 112.0, 113.1, 116.6, 125.7, 128.6, 132.7,
133.0, 135.3, 136.3, 136.6, 136.8, 140.1, 140.3, 140.5, 140.6, 142.0, 142.1,
142.13, 142.2, 142.4, 142.5, 142.53, 142.55, 142.6, 142.66, 142.7, 143.0,
143.1, 143.4, 143.5, 144.8, 144.9, 145.0, 145.05, 145.5, 145.6, 145.7, 145.72,
145.8, 145.9, 145.96, 146.1, 146.4, 146.5, 146.51, 146.6, 146.7, 146.9, 147.4,
147.7, 147.72, 148.6, 150.5, 154.3, 155.1, 156.8 ppm; FTIR (KBr): n˜ =526,
840, 1247, 1267, 1460, 1508 cmꢀ1; MS (ESI): m/z: 1009.9 [M+1]+.
(KBr): n˜ =526, 840, 866, 1388, 1654 cmꢀ1
; MS (ESI): m/z: 1063.0
[M+Na]+, 1077.9 [M+K]+.
Compound 14b: Yield 33% (56%). 1H NMR (CDCl3/CS2, 298 K,
200 MHz): d=2.05 (t, J=2.4 Hz, 1H; CH), 2.64–2.82 (m, 4H; 2CH2),
3.44 (s, 3H; CH3), 4.14 (brt, J=4.8 Hz, 1H; CHN), 4.24 (d, J=9.8 Hz,
1H; CH2N), 4.83 ppm (d, J=9.8 Hz, 1H; CH2N); 13C NMR (CDCl3/CS2,
298 K, 50 MHz): d=16.5, 29.9, 39.7, 69.7, 69.8, 70.0, 70.9, 75.7, 83.4,
135.3, 135.7, 136.0, 136.1, 137.1, 139.6, 139.8, 140.0, 140.05, 140.1, 141.6,
141.7, 141.8, 141.9, 141.96, 141.99, 142.0, 142.45, 142.47, 142.5, 142.51,
142.8, 142.9, 143.0, 144.1, 144.2, 144.3, 144.5, 145.0, 145.03, 145.09, 145.1,
145.2, 145.23, 145.26, 145.3, 145.5, 145.7, 145.8, 145.86, 145.9, 145.96,
145.99, 146.0, 146.06, 146.1, 146.14, 146.9, 147.0, 152.5, 153.8, 154.1, 154.5,
156.0 ppm; FTIR (KBr): n˜ =526.5, 1508.2, 2360 cmꢀ1; MS (ESI): m/z:
830.0 [M+1]+.
1
Compound 14c: Yield 90%. H NMR (CDCl3/CS2, 298 K, 500 MHz): d=
2.07 (s, 1H; CH), 2.76–2.83 (m, 3H; CH2), 2.93–3.06 (m, 1H; CH2), 5.31
(d, J=11.8 Hz, 1H; CH2N), 5.64 (brs, 1H; CH2N), 6,46 (brs, 1H; CHN),
7.52–7.56 (m, 3H; H Ar), 7.82–7.86 ppm (m, 2H; H Ar); 13C NMR
(CDCl3/CS2, 298 K, 125 MHz): d=17.2, 35.0, 58.7, 66.2, 70.3, 71.5, 74.6,
83.7, 128.7, 129.3, 131.3, 135.3, 135.5, 135.8, 137.2, 137.7, 140.5, 140.6,
140.7, 140.8, 142.1, 142.12, 142.4, 142.47, 142.5, 142.57, 142.6, 142.64,
142.7, 142.8, 142.9, 143.1, 143.16, 143.19, 143.2, 143.6, 143.7, 144.7, 144.8,
144.9, 145.0, 145.1, 145.3, 145.7, 145.8, 145.82, 145.85, 145.9, 146.0, 146.02,
146.1, 146.2, 146.4, 146.6, 146.7, 146.8, 147.8, 151.2, 152.8, 154.4, 155.3,
170.7 ppm; FTIR (KBr): n˜ =526.5, 1637 cmꢀ1; MS (ESI): m/z: 919.8
[M+1].
ꢀ
ꢀ
Compound 18a: Yield 55% (70%). 1H NMR (CDCl3/CS2, 298 K,
200 MHz): d=2.42 (t, J=2.38 Hz, 1H; CH), 2.86 (s, 3H; CH3N), 4.34 (d,
J=9.33 Hz, 1H; CH2N), 4.58 (AB syst., 2H; CH2O), 4.99 (d, J=9.33 Hz,
Synthesis of N-allylfulleropyrrolidine 6: NaH (0.625 mmol) was added to
solution of fulleropyrrolidine 2 (100 mg; 0.125 mmol) in o-DCB
a
ꢀ
(40 mL). After 5 min allyl bromide was added (0.375 mmol). The solution
was stirred for 18 h at 608C. The reaction was quenched with water
(20 mL). The organic layer was dried (MgSO4) and, after solvent remov-
al, the crude product was purified by flash chromatography over silica gel
(eluent: toluene/CS2 8:2) to give pure 6 in 55% yield. 1H NMR (CDCl3/
CS2, 298 K, 200 MHz): d=2.19 (t, J=2.7 Hz, 1H; CH), 3.24 (ddd, J=
17.3, 6.1, 2.7 Hz, 1H; CH2), 3.51 (ddd, J=17.3, 5.3, 2.7 Hz, 1H; CH2),
1H; CH2N), 5.61 (s, 1H; CHN), 6.87–7.33 (m, 3H; Ar H), 8.04 ppm (m,
1H; Ar H); 13C NMR (CDCl3/CS2, 298 K, 50 MHz): d=40.1, 56.1, 69.2,
ꢀ
69.7, 75.3, 75.6, 76.3, 78.1, 112.2, 122.2, 125.3, 128.2, 129.1, 130.1, 134.8,
136.1, 136.6, 139.5, 139.6, 140.1, 140.2, 141.5, 141.7, 141.8, 142.0, 142.1,
142.21, 142.26, 142.3, 142.35, 142.57, 142.58, 142.65, 142.68, 143.0, 143.07,
144.3, 144.4, 144.6, 145.1, 145.24, 145.27, 145.32, 145.35, 145.4, 145.6,
145.7, 145.95, 145.97, 146.0, 146.13, 146.17, 146.21, 146.26, 146.27, 146.6,
146.7, 147.2, 147.3, 156.3 ppm.
Compound 18b: Yield 50% (65%). 1H NMR (CDCl3/CS2, 298 K,
200 MHz): d=2.38 (t, J=2.3 Hz, 1H; CH), 2.78 (s, 3H; CH3N), 4.22 (d,
J=9.3 Hz, 1H; CH2N), 4.64 (d, J=2.3 Hz, 2H; CH2O), 4.86 (s, 1H;
ꢀ
ꢀ
3.56 (brdd, 1H; N CH2 C=), 4.14 (d, J=9.7 Hz, 1H; CH2N), 4.30 (brt,
ꢀ
ꢀ
1H; CHN), 4.36 (ddt, J=13.7, 5.1, 1.6 Hz, 1H; N CH2 C=), 4.86 (d, J=
9.7 Hz, 1H; CH2N), 5.43 (brd, 1H; C=CH2), 5.59 (ddd, J=17.09, 2.9,
1.6 Hz, 1H; CH=CH2), 6.35 ppm (m, 1H; CH=CH2); 13C NMR (CDCl3/
CS2, 298 K, 50 MHz): d=29.9, 66.5, 69.1, 72.6, 73.5, 75.0, 81.7, 118.8,
135.5, 135.6, 135.9, 136.2, 137.2, 137.7, 139.6, 140.1, 140.2, 140.9, 141.6,
141.8, 141.9, 142.07, 142.1, 142.5, 142.57, 142.6, 142.9, 143.9, 144.0, 144.3,
144.33, 144.5, 144.7, 145.1, 145.28, 145.2, 145.3, 145.4, 145.46, 145.5, 145.6,
145.8, 145.88, 145.9, 145.96, 146.0, 146.06, 146.1, 146.16, 146.2, 146.26,
146.3, 146.5, 146.9, 147.1, 147.2, 151.7, 153.8, 154.1, 155.9 ppm; FTIR
ꢀ
CHN), 4.92 (d, J=9.3 Hz, 1H; CH2N), 6.82–6.88 (m, 1H; Ar H), 7.20–
7.36 ppm (m, 3H; Ar H); 13C NMR (CDCl3/CS2, 298 K, 50 MHz): d=
ꢀ
40.1, 55.8, 69.0, 70.1, 75.7, 76.6, 78.8, 83.4, 115.5, 122.1, 125.0, 128.2, 128.6,
129.8, 135.0, 135.9, 136.6, 138.6, 139.6, 140.0, 141.6, 141.7, 141.8, 142.10,
142.11, 142.16, 142.3, 142.6, 143.7, 144.43, 144.69, 145.0, 145.2, 145.3,
145.4, 145.56, 145.59, 145.65, 146.0, 146.1, 146.2, 146.3, 146.4, 146.45,
146.6, 146.9, 147.3, 147.4, 147.63, 147.65, 147.7, 147.75, 147.8, 147.9, 148.1,
148.15, 153.3 ppm.
(KBr): n˜ =1558, 1508, 1458, 1419, 526 cmꢀ1
[M+H]+.
; MS (ESI): m/z: 842.3
Compound 18c: Yield 55% (70%). 1H NMR (CDCl3/CS2, 298 K,
200 MHz): d=2.49 (t, J=2.3 Hz, 1H; CH), 2.79 (s, 3H; CH3N), 4.25 (d,
J=9.2 Hz, 1H; CH2N), 4.67 (d, J=2.3 Hz, 2H; CH2O), 4.89 (s, 1H;
General procedure for the synthesis of N-methylfulleropyrrolidines 10a,
10c, 14b and 18a–c: mixture of the corresponding aldehyde
A
(0.694 mmol), C60 (250 mg, 0.347 mmol), and sarcosine (0.694 mmol) in o-
DCB (80 mL) was refluxed for 24 h. After cooling to room temperature,
the solvent was removed in vacuo and the crude product was purified by
flash chromatography over silica gel initially with CS2 as eluent (to sepa-
rate the unreacted fullerene) and then with toluene/CS2 (4:1) [for com-
pound 10a cyclohexane/CH2Cl2 (4:1) was used] to yield the correspond-
ing products.
ꢀ
CHN), 4.97 (d, J=9.2 Hz, 1H; CH2N), 7.00 (d, J=8.4 Hz, 2H; Ar H),
7.71 ppm (brs, 2H; Ar H); 13C NMR (CDCl3/CS2, 298 K, 50 MHz): d=
ꢀ
40.5, 56.3, 69.2, 70.1, 76.1, 79.0, 83.5, 115.5, 125.8, 127.8, 129.7, 136.2,
136.7, 137.0, 142.0, 142.1, 142.3, 142.4, 142.5, 142.52, 142.55, 142.58, 142.6,
142.7, 142.74, 143.0, 143.01, 143.04, 143.1, 143.4, 143.6, 144.8, 145.1, 145.2,
145.6, 145.7, 145.74, 145.8, 145.87, 145.9, 145.99, 146.0, 146.1, 146.2, 146.4,
146.42, 146.5, 146.62, 146.66, 146.7, 146.78, 146.8, 146.9, 147.1, 147.7,
157.8 ppm.
Compound 10a: Yield 24% (35%). 1H NMR (CDCl3/CS2, 298 K,
200 MHz): d=0.25 (2, 9H; (CH3)3Si), 2.81 (s, 3H; CH3), 4.35 (d, J=
Chem. Eur. J. 2005, 11, 2716 – 2729
ꢅ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2725